当前位置:首页 - 行情中心 - 仙琚制药(002332) - 财务分析

仙琚制药

(002332)

  

流通市值:96.49亿  总市值:96.94亿
流通股本:9.85亿   总股本:9.89亿

仙琚制药(002332)财务分析

净利润 + 每股收益
------
  • 净利润(亿元)
  • 每股收益(元)

    截至2025年半年度实现净利润2.96亿元,每股收益0.31元。

股东权益 + 未分配利润
------
  • 股东权益(亿元)
  • 未分配利润(亿元)

    截至2025年半年度最新股东权益603551.49万元,未分配利润263921.08万元。

总资产 + 负债
------
  • 总资产(亿元)
  • 负债(亿元)

    截至2025年半年度最新总资产724841.54万元,负债121290.05万元。

利润表
报告期2025-06-302025-03-312024-12-312024-09-30
营业总收入1,869,227,375.541,008,198,242.34,000,693,148.053,237,007,358.82
营业总成本1,540,784,233.35843,841,353.083,310,485,780.212,606,344,910.38
其他经营收益
营业利润347,041,392.99158,616,498.31678,211,239.17630,727,222.82
利润总额343,329,220.64157,880,073498,327,195.31627,710,393.41
净利润296,096,657.34138,163,788.77399,923,214.68542,697,542.2
每股收益
其他综合收益149,107,625.7846,221,040.19-64,136,651.01-5,397,470.36
综合收益总额445,204,283.12184,384,828.96335,786,563.67537,300,071.84
资产负债表
报告期2025-06-302025-03-312024-12-312024-09-30
流动资产:
流动资产合计3,313,814,356.073,327,667,195.763,263,717,834.913,198,646,646.36
非流动资产:
非流动资产合计3,934,601,051.893,800,975,081.423,735,871,374.783,709,093,514.44
资产总计7,248,415,407.967,128,642,277.186,999,589,209.696,907,740,160.8
流动负债:
流动负债合计1,072,911,395.42716,880,084.65778,089,858.12737,706,582.47
非流动负债:
非流动负债合计139,989,121.16338,305,295.51333,327,283.51101,449,192.86
负债合计1,212,900,516.581,055,185,380.161,111,417,141.63839,155,775.33
所有者权益(或股东权益):
归属于母公司股东权益合计6,004,117,728.456,033,708,337.975,843,503,305.496,014,143,118.38
股东权益合计6,035,514,891.386,073,456,897.025,888,172,068.066,068,584,385.47
负债和股东权益合计7,248,415,407.967,128,642,277.186,999,589,209.696,907,740,160.8
现金流量表
报告期2025-06-302025-03-312024-12-312024-09-30
经营活动产生的现金流量:
经营活动现金流入小计1,749,866,258.79809,426,287.893,639,376,094.542,676,018,442.73
经营活动现金流出小计1,750,196,244.34791,004,555.873,240,720,719.152,458,592,364.89
经营活动产生的现金流量净额-329,985.5518,421,732.02398,655,375.39217,426,077.84
投资活动产生的现金流量:
投资活动现金流入小计23,662.666,405.3467,465,213.4467,777,522.76
投资活动现金流出小计136,621,783.2769,740,347.25247,886,758.86209,752,623.38
投资活动产生的现金流量净额-136,598,120.61-69,733,941.91-180,421,545.42-141,975,100.62
筹资活动产生的现金流量:
筹资活动现金流入小计328,933,205.1310,206,279.639,069,286.795,000,000
筹资活动现金流出小计309,821,379.045,073,879.77474,894,142.65420,007,804.2
筹资活动产生的现金流量净额19,111,826.095,132,399.86-465,824,855.86-415,007,804.2
汇率变动对现金及现金等价物的影响42,751,638.3824,611,399.83-6,127,786.58-965,194.56
现金及现金等价物净增加额-75,064,641.69-21,568,410.2-253,718,812.47-340,522,021.54
期末现金及现金等价物余额1,301,067,506.061,354,563,737.551,376,132,147.751,289,328,938.68
补充资料:
现金及现金等价物的净增加额-75,064,641.69--253,718,812.47-
最新报告期:2025-09-07
研究机构分析师预测每股收益(元)更新日
2025年2026年2027年
华创证券郑辰,王宏雨0.590.630.732025-09-07
东方证券伍云飞0.610.700.862025-09-03
中泰证券祝嘉琦0.640.720.842025-09-03
财通证券华挺,邹一瑜0.580.670.782025-09-01
华泰证券代雯,李奕玮0.580.640.762025-08-27
TOP↑